Cencora, Inc. (NYSE:COR) CEO Robert P. Mauch Sells 4,968 Shares

Cencora, Inc. (NYSE:COR - Get Free Report) CEO Robert P. Mauch sold 4,968 shares of the stock in a transaction that occurred on Friday, July 18th. The stock was sold at an average price of $294.11, for a total transaction of $1,461,138.48. Following the completion of the sale, the chief executive officer owned 42,351 shares in the company, valued at $12,455,852.61. This represents a 10.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Cencora Trading Down 0.1%

NYSE:COR traded down $0.28 during trading hours on Friday, reaching $290.17. The company's stock had a trading volume of 785,267 shares, compared to its average volume of 1,072,635. The firm has a market capitalization of $56.24 billion, a price-to-earnings ratio of 33.66, a PEG ratio of 1.44 and a beta of 0.57. The firm has a 50-day simple moving average of $293.31 and a 200-day simple moving average of $274.53. Cencora, Inc. has a 1 year low of $218.65 and a 1 year high of $309.35. The company has a debt-to-equity ratio of 6.01, a quick ratio of 0.52 and a current ratio of 0.87.

Cencora (NYSE:COR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $4.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.07 by $0.35. Cencora had a net margin of 0.55% and a return on equity of 344.71%. The business had revenue of $75.50 billion for the quarter, compared to analyst estimates of $75.41 billion. During the same quarter last year, the firm earned $3.80 EPS. The company's revenue was up 10.3% on a year-over-year basis. Research analysts expect that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Friday, May 16th were given a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date was Friday, May 16th. Cencora's payout ratio is 25.52%.

Analyst Ratings Changes

COR has been the topic of several recent analyst reports. Robert W. Baird increased their target price on shares of Cencora from $314.00 to $350.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Citigroup increased their target price on shares of Cencora from $330.00 to $355.00 and gave the stock a "buy" rating in a research note on Thursday, May 8th. UBS Group increased their target price on shares of Cencora from $298.00 to $335.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Wells Fargo & Company upgraded shares of Cencora from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $274.00 to $337.00 in a research report on Tuesday, June 3rd. Finally, Jefferies Financial Group raised their price objective on shares of Cencora from $275.00 to $300.00 and gave the company a "hold" rating in a research report on Monday, June 30th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $309.83.

Hedge Funds Weigh In On Cencora

A number of hedge funds have recently modified their holdings of COR. Sciencast Management LP purchased a new position in shares of Cencora in the fourth quarter valued at about $243,000. Mizuho Securities USA LLC boosted its stake in shares of Cencora by 46.9% during the 4th quarter. Mizuho Securities USA LLC now owns 16,621 shares of the company's stock valued at $3,734,000 after purchasing an additional 5,309 shares in the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of Cencora during the 4th quarter valued at about $19,543,000. Fox Run Management L.L.C. boosted its stake in shares of Cencora by 19.2% during the 4th quarter. Fox Run Management L.L.C. now owns 3,665 shares of the company's stock valued at $823,000 after purchasing an additional 591 shares in the last quarter. Finally, Blueprint Investment Partners LLC bought a new stake in shares of Cencora during the 4th quarter valued at about $269,000. Hedge funds and other institutional investors own 97.52% of the company's stock.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.